A Study of Lu AG06466 for the Treatment of Spasticity in Participants With Multiple Sclerosis

NCT04990219 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

37

Enrollment

INDUSTRY

Sponsor class

Stopped The study was terminated for strategic reasons

Conditions

Multiple Sclerosis

Interventions

DRUG: Lu AG06466
DRUG: Placebo

Sponsor

H. Lundbeck A/S